849 related articles for article (PubMed ID: 10446734)
1. Pharmacology of antidepressants: selectivity or multiplicity?
Westenberg HG
J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
[TBL] [Abstract][Full Text] [Related]
2. Development of new antidepressants.
Sambunaris A; Hesselink JK; Pinder R; Panagides J; Stahl SM
J Clin Psychiatry; 1997; 58 Suppl 6():40-53. PubMed ID: 9227672
[TBL] [Abstract][Full Text] [Related]
3. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
Stahl SM
J Clin Psychiatry; 1998; 59 Suppl 4():5-14. PubMed ID: 9554316
[TBL] [Abstract][Full Text] [Related]
4. Designing a new generation of antidepressant drugs.
Pinder RM
Acta Psychiatr Scand Suppl; 1997; 391():7-13. PubMed ID: 9265946
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of rapid-onset antidepressant treatment strategies.
Blier P
J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
[TBL] [Abstract][Full Text] [Related]
6. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
7. Mirtazapine: pharmacology in relation to adverse effects.
Nutt D
Acta Psychiatr Scand Suppl; 1997; 391():31-7. PubMed ID: 9265949
[TBL] [Abstract][Full Text] [Related]
8. Possible neurobiological mechanisms underlying faster onset of antidepressant action.
Blier P
J Clin Psychiatry; 2001; 62 Suppl 4():7-11; discussion 37-40. PubMed ID: 11229789
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine: clinical overview.
Gorman JM
J Clin Psychiatry; 1999; 60 Suppl 17():9-13; discussion 46-8. PubMed ID: 10446735
[TBL] [Abstract][Full Text] [Related]
10. The pharmacologic profile of mirtazapine.
de Boer T
J Clin Psychiatry; 1996; 57 Suppl 4():19-25. PubMed ID: 8636062
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
Davis R; Wilde MI
CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
[TBL] [Abstract][Full Text] [Related]
12. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission.
de Boer T
Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():19-23. PubMed ID: 8930006
[TBL] [Abstract][Full Text] [Related]
13. [Two new antidepressants: mirtazapine and venlafaxine].
Birkenhäger TK; Moleman P
Ned Tijdschr Geneeskd; 1999 May; 143(18):934-7. PubMed ID: 10368708
[TBL] [Abstract][Full Text] [Related]
14. Tolerability and safety aspects of mirtazapine.
Nutt DJ
Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-41. PubMed ID: 12404669
[TBL] [Abstract][Full Text] [Related]
15. The dual-action hypothesis: does pharmacology matter?
Shelton RC
J Clin Psychiatry; 2004; 65 Suppl 17():5-10. PubMed ID: 15600376
[TBL] [Abstract][Full Text] [Related]
16. Noradrenergic approaches to antidepressant therapy.
Gorman JM; Sullivan G
J Clin Psychiatry; 2000; 61 Suppl 1():13-6. PubMed ID: 10703758
[TBL] [Abstract][Full Text] [Related]
17. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects.
Dell'Osso B; Palazzo MC; Oldani L; Altamura AC
CNS Neurosci Ther; 2011 Dec; 17(6):723-32. PubMed ID: 21155988
[TBL] [Abstract][Full Text] [Related]
18. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
Fawcett J; Barkin RL
J Affect Disord; 1998 Dec; 51(3):267-85. PubMed ID: 10333982
[TBL] [Abstract][Full Text] [Related]
19. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants.
Yokogawa F; Kiuchi Y; Ishikawa Y; Otsuka N; Masuda Y; Oguchi K; Hosoyamada A
Anesth Analg; 2002 Jul; 95(1):163-8, table of contents. PubMed ID: 12088962
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants.
Frazer A
J Clin Psychiatry; 1997; 58 Suppl 6():9-25. PubMed ID: 9227669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
